WHO ICTRP trial
Dose-dependent effects of propranolol on extinction learning and return of fear
EUCTR2018-003409-25-BE · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2018-003409-25-BE |
|---|---|
| Public title | Dose-dependent effects of propranolol on extinction learning and return of fear |
| Scientific title | Dose-dependent effects of propranolol on extinction learning and return of fear - WipeOutFear_Extinction |
| Primary sponsor | KU Leuven |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): no Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): yes |
| Countries | Belgium |
| Conditions | Experimental study with healthy participants recruited from the general population; no vulnerable individuals or clinical groups will be involved. Our objective is to test whether propranolol administration has a dose-dependent effect on… |
| Interventions | Trade Name: Propranolol EG (Eurogenerics NV) - 40 mg Product Name: Propranolol Product Code: C07AA05 Pharmaceutical Form: Tablet INN or Proposed INN: PROPRANOLOL HYDROCHLORIDE CAS Number: 318-98-9 Concentration unit: mg milligram(s)… |
| Registration date | Feb 10, 2018 |
| Target size | 144 |
| Secondary IDs | S61887 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: